Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: An AIDS clinical trials group (ACTG) longitudinal linked randomized trials (ALLRT) analysis

HIV Clinical Trials

Volumn 12, Issue 4, 2011, Pages 190-200

  Krishnan, S ^a   Wu, K ^a   Smurzynski, M ^a   Bosch, R J ^a   Benson, C A ^b   Collier, A C ^c   Klebert, M K ^d   Feinberg, J ^e   Koletar, S L ^f  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

bias; HIV; incidence; loss to follow up; prospective cohort; risk factors

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; DEATH; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INTRAVENOUS DRUG ABUSE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OLIGOPHRENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 80455129904     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1310/HCT1204-190     Document Type: Article

References (31)

1. MacLachlan M. Never say lost: A practical guide for maintaining participant follow-up in clinical trials. Pittsburgh, PA: National Surgical Adjuvant Breast and Bowel Project. 2004. http://www.nsabp.pitt.edu/Never-Say- Lost.pdf. Accessed on December 13, 2010.
2. Lanoy E, Lewden C, Lievre L, et al. How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalite 2000 survey and death certificates. HIV Med. 2009;10:236-245.
3. Geng EH, Emenyonu N, Bwana MB, et al. Sampling-base approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008;300(5):506-507.
4. Lok JJ, Bosch RJ, Benson CA, et al. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS. 2010;24:1867-1876.
5. Giordano TP, Gifford AL, White AC, et al. Retention in care: A challenge to survival with HIV infection. CID. 2007;44(1 June):1493-1499.
6. Smurzynski M. Collier AC, Koletar S, et al. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): Rationale, design, and baseline characteristics. HIV Clin Trials. 2008;9(4):269-282.
7. Lebouche B, Yazdanpanah Y, Gerard DS, et al. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med. 2006;7:140-145.
8. Ndiaye B, Ould-Kaci K, Salleron J, et al Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France- January 1997 to December 2006. Antivir Ther. 2009;14(4): 567-575.
9. Mocroft A, Kirk O, Aldins P, et al. Loss to follow-up in an international multicentre observational study. HIV Med. 2008;9:261-269.
10. Dudley J, Jin S, Hoover D, et al. The multicenter AIDS cohort study: Retention after 9 1/2 years. Am J Epidemiol. 1995;142(3):323-330
11. Hessol NA, Weber KM, Holman S, et al. Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. J Women Health. 2009;18(10):1627-1637.
12. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010;376(9734):49-62
13. Lanoy E, Mary-Krause M, Tattevin P, et al. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol. 2006;59:829-835.
14. Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status as a determinant of adherence to treatment in HIV-infected patients: A systematic review of the literature. Retrovirology. 2008;5(13).
15. Radler BT, Ryff CD. Who participates? Longitudinal retention in the MODUS National Study of health and wellbeing. J Aging Health. 2010;22(3):307-331.
16. Prime K, Sethi G, Navaratne L, et al. Differences in presentation and follow-up between HIV-1 antibody positive teenagers and adults: The need for a more focused approach to care? AIDS. 2003;17(2):260-262.
17. Hill T, Bansi L, Sabin C, et al. Data linkage reduces loss to follow-up in an observational HIV cohort study. J Clin Epidemiol. 2010;63(10):1101-1109.
18. Arici C, Ripamonti D, Maggiolo F, et al. Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clin Trials. 2002;3(1):52-57.
19. Migration of the Young, Single and College Educated: 1995 to 2000. Census 2000 Special Reports. Washington, DC: US Census Bureau; November 2003.
20. Ross CE, Wu C. The links between education and health. Am Sociol Rev. 1995;60(5):719-745.
21. Adler NE, Newman K. Socioeconomic disparities and health: Pathways and policies. Health Affairs. 2002;21(2):60-76.
22. Ioannidis JPA, Bassett R, Hughes MD, et al. Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Aquir Immune Defic Syndrome. 1997;16:22-30.
23. Andersen JW, Fass R, Horst C. Factors associated with early study discontinuation in AACTG clinical trials, DACS 200. Contemp Clin Trials. 2007;28:583-592.
24. Domestic Migration Across Regions, Divisions and States: 1995-2000. Census 2000 Special Reports. Washington, DC: US Census Bureau; August 2003.
25. Domestic Net Migration in the United States: 2000 to 2004. Population Estimates and Projections. Census 2000 Special Reports. Washington, DC: US Census Bureau; April 2006.
26. Brown DM, Thorne JE, Foster JL, et al. Factors affecting attrition in a longitudinal study of patients with AIDS. AIDS Care. 2006;18(7):821-829.
27. Cheever LW. Editorial commentary: Engaging HIV-infected patients in care: Their lives depend on it. Clin Infect Dis. 2007;44(11):1500-1502.
28. Horstmann E, Brown J, Islam F, Buck J, Agins BD. HIV/AIDS: Retaining HIV-infected patients in care: Where are we? Where do we go from here? Clin Infect Dis. 2010;50(5): 752-761.
29. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: A meta-analysis. AIDS. 2010; 24(17):2665-2678.
30. Robins JM, Rotnitzky A, Zhao LP. Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. J Am Stat Assoc. 1995;90:106-121.
31. Cole RC, Hernan MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;186:656-664